{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:16:30Z","timestamp":1707524190245},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,8]]},"DOI":"10.7759\/cureus.10856","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T17:43:01Z","timestamp":1602178981000},"source":"Crossref","is-referenced-by-count":2,"title":["Calcium Alkali Thiazide Syndrome: What We Need to Know"],"prefix":"10.7759","author":[{"given":"Mehboob A","family":"Rehan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Krell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Gabutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reema","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Sadiq NM, Naganathan S, Badireddy M. (Hypercalcemia). https.\/\/www.ncbi.nlm.nih.gov\/books\/NBK430714\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.749","article-title":"Prevalence of hypercalcemia among cancer patients in the United States","volume":"5","author":"Gastanaga MV","year":"2016","unstructured":"Gastanaga MV, Schwartzberg SL, Jain KR, et al.. Prevalence of hypercalcemia among cancer patients in the United States. Cancer Med. 2016, 5:2091-2100. 10.1002\/cam4.749","journal-title":"Cancer Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5049\/EBP.2010.8.2.66","article-title":"Acid-base disorders in ICU patients","volume":"8","author":"Oh YK","year":"2010","unstructured":"Oh YK. Acid-base disorders in ICU patients. Electrolytes Blood Pressure. 2010, 8:66-71.  10.5049\/EBP.2010.8.2.66","journal-title":"Electrolytes Blood Pressure"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5430\/crim.v5n2p31","article-title":"Hypercalcemia due to milk alkali syndrome: An emerging cause of hypercalcemia: a case report and review of literature","volume":"5","author":"Pandey Y","year":"2018","unstructured":"Pandey Y, Joshi KP, Priyambada P, et al.. Hypercalcemia due to milk alkali syndrome: An emerging cause of hypercalcemia: a case report and review of literature. Case Rep Internal Med. 2018, 5:10.5430\/crim.v5n2p31","journal-title":"Case Rep Internal Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcpc1503829","article-title":"Case 24-2016: a 66-year-old man with Malaise, weakness, and hypercalcemia","volume":"375","author":"Bazari H","year":"2016","unstructured":"Bazari H, Palmer WE, Baron JM, et al.. Case 24-2016: a 66-year-old man with Malaise, weakness, and hypercalcemia. New Engl J Med. 2016, 375:567-574. 10.1056\/NEJMcpc1503829","journal-title":"New Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1915.02570460001001","article-title":"Gastric and duodenal ulcer: medical cure by an efficient removal of gastric juice corrosion","volume":"64","author":"Sippy BW","year":"1915","unstructured":"Sippy BW. Gastric and duodenal ulcer: medical cure by an efficient removal of gastric juice corrosion. J Am Med Assoc. 1915, 64:1625-1630. 10.1001\/jama.1915.02570460001001","journal-title":"J Am Med Assoc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01451005","article-title":"Milk alkali syndrome and the dynamics of calcium homeostasis","volume":"1","author":"Felsenfeld AJ","year":"2006","unstructured":"Felsenfeld AJ, Levine BS. Milk alkali syndrome and the dynamics of calcium homeostasis. Clin J Am Soc Nephrol. 2006, 1:641-654. 10.2215\/CJN.01451005","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4065\/84.3.261","article-title":"Milk-alkali syndrome","volume":"84","author":"Medarov B","year":"2009","unstructured":"Medarov B. Milk-alkali syndrome. Mayo Clinic Proc. 2009, 84:261-267. 10.4065\/84.3.261","journal-title":"Mayo Clinic Proc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/nu5124880","article-title":"Calcium-alkali syndrome in the modern era","volume":"5","author":"Patel AM","year":"2013","unstructured":"Patel AM, Adeseun GA, Goldfarb S. Calcium-alkali syndrome in the modern era. Nutrients. 2013, 5:4880-4893. 10.3390\/nu5124880","journal-title":"Nutrients"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02383.x","article-title":"Milk-alkali syndrome is a major cause of hypercalcaemia among non\u2010end\u2010stage renal disease (non\u2010ESRD) inpatients","volume":"63","author":"Picolos MK","year":"2005","unstructured":"Picolos MK, Lavis VR, Orlander PR. Milk-alkali syndrome is a major cause of hypercalcaemia among non\u2010end\u2010stage renal disease (non\u2010ESRD) inpatients. Clin Endocrinol. 2005, 63:566-576. 10.1111\/j.1365-2265.2005.02383.x","journal-title":"Clin Endocrinol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.63.736.111","article-title":"Fatal hyperparathyroid crisis","volume":"63","author":"Keeling CA","year":"1987","unstructured":"Keeling CA, Abrahamson MJ, Harloe DG. Fatal hyperparathyroid crisis. Postgrad Med J. 1987, 63:111-112. 10.1136\/pgmj.63.736.111","journal-title":"Postgrad Med J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-223772","article-title":"Treatment of extreme hypercalcaemia: the role of haemodialysis","volume":"2018","author":"Basok AB","year":"2018","unstructured":"Basok AB, Rogachev B, Haviv YS, et al.. Treatment of extreme hypercalcaemia: the role of haemodialysis. Case Rep. 2018, 2018:bcr-2017-223772. 10.1136\/bcr-2017-223772","journal-title":"Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2005.01506.x","article-title":"Surviving extreme hypercalcaemia-a case report and review of the literature","volume":"258","author":"Marienhagen K","year":"2005","unstructured":"Marienhagen K, Due J, Hanssen TA, et al.. Surviving extreme hypercalcaemia-a case report and review of the literature. J Internal Med. 2005, 258:86-89. 10.1111\/j.1365-2796.2005.01506.x","journal-title":"J Internal Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90552-1","article-title":"Rolaids-yogurt syndrome: a 1990s version of milk-alkali syndrome","volume":"27","author":"Muldowney WP","year":"1996","unstructured":"Muldowney WP, Mazbar SA. Rolaids-yogurt syndrome: a 1990s version of milk-alkali syndrome. Am J Kidney Dis. 1996, 27:270-272. 10.1016\/S0272-6386(96)90552-1","journal-title":"Am J Kidney Dis"},{"key":"ref15","article-title":"Decreased aquaporin-2 expression and apical plasma membrane delivery in kidney collecting ducts of polyuric hypercalcemic rats","volume":"9","author":"Earm JH","year":"1998","unstructured":"Earm JH, Christensen BM, Fr\u00f8kiaer J, et al.. Decreased aquaporin-2 expression and apical plasma membrane delivery in kidney collecting ducts of polyuric hypercalcemic rats. J Am Soc Nephrol. 1998, 9:2181-2193.","journal-title":"J Am Soc Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.12.005","article-title":"Hypercalcemia induces targeted autophagic degradation of aquaporin-2 at the onset of nephrogenic diabetes insipidus","volume":"91","author":"Khositseth S","year":"2017","unstructured":"Khositseth S, Charngkaew K, Boonkrai C, et al.. Hypercalcemia induces targeted autophagic degradation of aquaporin-2 at the onset of nephrogenic diabetes insipidus. Kidney Int. 2017, 91:1070-1087. 10.1016\/j.kint.2016.12.005","journal-title":"Kidney Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/1947-2714.170600","article-title":"Hypercalcemia of malignancy: an update on pathogenesis and management","volume":"7","author":"Mirrakhimov AE","year":"2015","unstructured":"Mirrakhimov AE. Hypercalcemia of malignancy: an update on pathogenesis and management. North Am J Med Sci. 2015, 7:483-493. 10.4103\/1947-2714.170600","journal-title":"North Am J Med Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2012.11.010","article-title":"Hypercalcemia in the ED: prevalence, etiology, and outcome","volume":"31","author":"Lindner G","year":"2013","unstructured":"Lindner G, Felber R, Schwarz C, et al.. Hypercalcemia in the ED: prevalence, etiology, and outcome. Am J Emerg Med. 2013, 31:657-660. 10.1016\/j.ajem.2012.11.010","journal-title":"Am J Emerg Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S83681","article-title":"Hypercalcemia of malignancy and new treatment options","volume":"11","author":"Sternlicht H","year":"2015","unstructured":"Sternlicht H, Glezerman I. Hypercalcemia of malignancy and new treatment options. Therapeutics Clin Risk Manage. 2015, 11:1779-1788. 10.2147\/TCRM.S83681","journal-title":"Therapeutics Clin Risk Manage"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/39919-calcium-alkali-thiazide-syndrome-what-we-need-to-know","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:08Z","timestamp":1707506828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/39919-calcium-alkali-thiazide-syndrome-what-we-need-to-know"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.10856","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,8]]}}}